Company intelligence / Profile preview

Kaiko.ai

Amsterdam, North Holland, Netherlands

Ownership: Private
Employees: ~76
Development stage: Other

Overview

Kaiko.ai enables hospitals/research institutes to access petascale multimodal medical datasets and provide clinicians with AI-powered support, especially for cancer treatment decisions. Their kaiko.w assistant is deployed in live workflows with leading hospitals, supports decision-making from EMR/EHR, images, genomics, and offers agentic reasoning models validated in clinical practice.

Therapeutic areas: Oncology
Modalities: AI models applied to oncology data
Industry: Digital Health Medical Devices

Partnerships

Netherlands Cancer Institute (NKI–AVL)

Beyond the preview

Go deeper on Kaiko.ai.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kaiko.ai.

Explore the full profile